These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2181208)
21. Critical periods of prenatal toxic insults. Goldman AS Prog Clin Biol Res; 1980; 36():9-31. PubMed ID: 6995988 [No Abstract] [Full Text] [Related]
22. Effects of drugs and chemicals on the fetus and newborn (2). Hill LM; Kleinberg F Mayo Clin Proc; 1984 Nov; 59(11):755-65. PubMed ID: 6387317 [TBL] [Abstract][Full Text] [Related]
23. Drug use in pregnancy: how to avoid problems. Rao JM; Arulappu R Drugs; 1981 Nov; 22(5):409-14. PubMed ID: 6120825 [TBL] [Abstract][Full Text] [Related]
24. Drug-exposed neonates. Hoegerman G; Wilson CA; Thurmond E; Schnoll SH West J Med; 1990 May; 152(5):559-64. PubMed ID: 2190424 [TBL] [Abstract][Full Text] [Related]
25. Preliminary evidence for a cocaine-induced embryopathy in mice. Finnell RH; Toloyan S; van Waes M; Kalivas PW Toxicol Appl Pharmacol; 1990 Apr; 103(2):228-37. PubMed ID: 2330587 [TBL] [Abstract][Full Text] [Related]
26. Cocaine: clinical studies of pregnancy and the newborn. Chasnoff IJ; Griffith DR Ann N Y Acad Sci; 1989; 562():260-6. PubMed ID: 2742283 [No Abstract] [Full Text] [Related]
27. Arrhenius thermodynamics and birth defects: chemical teratogen synergy. Untested, testable, and projected relevance. Miller MW; Church CC Birth Defects Res C Embryo Today; 2013 Mar; 99(1):50-60. PubMed ID: 23723172 [TBL] [Abstract][Full Text] [Related]
28. Maternal periconceptional illicit drug use and the risk of congenital malformations. van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N; Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385 [TBL] [Abstract][Full Text] [Related]
29. Use of birth defects monitoring programs for assessing the effects of maternal substance abuse on pregnancy outcomes. Martin ML; Edmonds LD NIDA Res Monogr; 1991; 114():66-83. PubMed ID: 1754024 [TBL] [Abstract][Full Text] [Related]
30. Environmental pollution and pregnancy: risks and uncertainties for the fetus and infant. Longo LD Am J Obstet Gynecol; 1980 May; 137(2):162-73. PubMed ID: 6246801 [TBL] [Abstract][Full Text] [Related]
31. The cardiovascular effects of cocaine use in pregnancy. Plessinger MA; Woods JR Reprod Toxicol; 1991; 5(2):99-113. PubMed ID: 1807550 [No Abstract] [Full Text] [Related]
32. Functional teratogenic effects of chemicals on the developing brain. Swaab DF; Mirmiran M Monogr Neural Sci; 1986; 12():45-57. PubMed ID: 3796647 [No Abstract] [Full Text] [Related]
33. Cocaine exposure in utero: perinatal development and neonatal manifestations--review. Kain ZN; Kain TS; Scarpelli EM J Toxicol Clin Toxicol; 1992; 30(4):607-36. PubMed ID: 1433431 [TBL] [Abstract][Full Text] [Related]
35. The puzzle of cocaine's effects following maternal use during pregnancy: are there reconcilable differences? Hutchings DE Neurotoxicol Teratol; 1993; 15(5):281-6. PubMed ID: 8277914 [TBL] [Abstract][Full Text] [Related]
36. [A risk analysis of congenital defects due to drug intake during pregnancy. Spanish Collaborative Study of Congenital Malformations]. Martínez-Frías ML Med Clin (Barc); 1999 Jan; 112(2):41-4. PubMed ID: 10065427 [TBL] [Abstract][Full Text] [Related]
37. Cardiac teratogenicity of trichloroethylene metabolites. Johnson PD; Dawson BV; Goldberg SJ J Am Coll Cardiol; 1998 Aug; 32(2):540-5. PubMed ID: 9708489 [TBL] [Abstract][Full Text] [Related]